$291 Million is the total value of DAFNA Capital Management LLC's 81 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 24.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $72,370,000 | +50.7% | 13,680,554 | 0.0% | 24.84% | +37.6% | |
| PRQR | Buy | PROQR THERAPEUTICS N V | $11,040,000 | +633.1% | 1,114,000 | +326.0% | 3.79% | +569.4% |
| ATRC | ATRICURE INC | $10,362,000 | +30.4% | 318,729 | 0.0% | 3.56% | +19.0% | |
| ARQL | Sell | ARQULE INC | $9,935,000 | +161.3% | 497,762 | -6.1% | 3.41% | +138.5% |
| BPMC | BLUEPRINT MEDICINES CORP | $9,871,000 | +9.0% | 123,218 | 0.0% | 3.39% | -0.5% | |
| GLPG | Sell | GALAPAGOS NVspon adr | $9,721,000 | +21.3% | 47,000 | -10.5% | 3.34% | +10.7% |
| FATE | FATE THERAPEUTICS INC | $9,198,000 | +26.0% | 470,000 | 0.0% | 3.16% | +15.0% | |
| SAGE | SAGE THERAPEUTICS INC | $9,010,000 | -48.5% | 124,806 | 0.0% | 3.09% | -53.0% | |
| DXCM | DEXCOM INC | $7,949,000 | +46.6% | 36,338 | 0.0% | 2.73% | +33.8% | |
| IBB | ISHARES TR NASDAQ BIOTECHetf | $7,821,000 | +21.1% | 64,900 | 0.0% | 2.68% | +10.5% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $6,558,000 | +12.8% | 61,008 | -5.4% | 2.25% | +3.0% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $6,474,000 | +17.0% | 267,839 | -6.9% | 2.22% | +6.8% |
| ZGNX | Sell | ZOGENIX INC | $5,565,000 | -2.6% | 106,749 | -25.2% | 1.91% | -11.2% |
| CARA | Sell | CARA THERAPEUTICS INC | $5,293,000 | -23.6% | 328,533 | -13.3% | 1.82% | -30.2% |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $4,870,000 | +50.0% | 770,538 | -6.9% | 1.67% | +36.9% |
| LMNX | LUMINEX CORP | $4,727,000 | +12.2% | 204,091 | 0.0% | 1.62% | +2.4% | |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $4,494,000 | +4.5% | 98,942 | +5.3% | 1.54% | -4.6% |
| CYTK | CYTOKINETICS INC | $4,443,000 | -6.8% | 418,727 | 0.0% | 1.52% | -14.9% | |
| BHVN | Sell | BIOHAVEN PHARMACEUTICALS HOLD | $4,067,000 | +2.6% | 74,700 | -21.4% | 1.40% | -6.3% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $3,909,000 | -32.9% | 28,100 | -53.5% | 1.34% | -38.7% |
| MNLO | Sell | MENLO THERAPEUTICS INC | $3,701,000 | -3.6% | 797,565 | -6.9% | 1.27% | -12.0% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,395,000 | -7.4% | 4,000,000 | 0.0% | 1.16% | -15.5% | ||
| XENE | Sell | XENON PHARMACEUTICALS INC | $3,262,000 | +9.5% | 248,854 | -24.7% | 1.12% | 0.0% |
| AFMD | New | AFFIMED NV | $3,106,000 | – | 1,133,559 | +100.0% | 1.07% | – |
| ACHN | ACHILLION PHARMACEUTICALS | $2,646,000 | +67.5% | 438,884 | 0.0% | 0.91% | +52.9% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $2,606,000 | +53.4% | 118,314 | 0.0% | 0.90% | +40.1% | |
| BEAT | Buy | BIOTELEMETRY INC | $2,560,000 | +38.8% | 55,300 | +22.1% | 0.88% | +26.7% |
| ALEC | ALECTOR INC | $2,498,000 | +19.5% | 145,000 | 0.0% | 0.86% | +9.0% | |
| KURA | Buy | KURA ONCOLOGY INC | $2,385,000 | +51.7% | 173,475 | +67.4% | 0.82% | +38.6% |
| CSII | CARDIOVASCULAR SYSTEMS INC | $2,245,000 | +2.3% | 46,200 | 0.0% | 0.77% | -6.7% | |
| BLUE | BLUEBIRD BIO INC | $2,238,000 | -4.4% | 25,500 | 0.0% | 0.77% | -12.7% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $2,203,000 | +46.6% | 360,542 | 0.0% | 0.76% | +33.8% | |
| ARAY | ACCURAY INC | $1,902,000 | +1.8% | 674,300 | 0.0% | 0.65% | -7.1% | |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $1,894,000 | +6.5% | 30,408 | -35.7% | 0.65% | -2.8% |
| ARCT | ARCTURUS THERAPEUTICS HLDG I | $1,890,000 | +5.8% | 173,914 | 0.0% | 0.65% | -3.4% | |
| OTIC | New | OTONOMY INC | $1,797,000 | – | 469,135 | +100.0% | 0.62% | – |
| STIM | Buy | NEURONETICS INC | $1,777,000 | +101.2% | 395,772 | +272.5% | 0.61% | +83.7% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $1,773,000 | +28.0% | 514,051 | +6.3% | 0.61% | +16.9% |
| KDMN | Sell | KADMON HOLDINGS INC | $1,696,000 | -24.0% | 374,423 | -57.7% | 0.58% | -30.7% |
| VKTX | VIKING THERAPEUTICS INC | $1,678,000 | +16.6% | 209,200 | 0.0% | 0.58% | +6.5% | |
| EPZM | Sell | EPIZYME INC | $1,673,000 | +33.0% | 68,000 | -44.3% | 0.57% | +21.4% |
| MGNX | Sell | MACROGENICS INC | $1,632,000 | -36.1% | 150,000 | -25.0% | 0.56% | -41.7% |
| AGTC | APPLIED GENETIC TECHNOL CORP | $1,624,000 | +8.7% | 359,190 | 0.0% | 0.56% | -0.9% | |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | $1,623,000 | +12.1% | 297,300 | 0.0% | 0.56% | +2.2% | |
| INGN | INOGEN INC | $1,572,000 | +42.6% | 23,000 | 0.0% | 0.54% | +30.4% | |
| ELOX | Sell | ELOXX PHARMACEUTICALS INC | $1,515,000 | -10.6% | 205,825 | -45.1% | 0.52% | -18.4% |
| ARDX | Sell | ARDELYX INC | $1,500,000 | -45.0% | 199,850 | -65.6% | 0.52% | -49.8% |
| TBIO | Sell | TRANSLATE BIO INC | $1,464,000 | -59.4% | 179,845 | -50.6% | 0.50% | -63.0% |
| NTUS | NATUS MEDICAL INC | $1,415,000 | +3.6% | 42,900 | 0.0% | 0.49% | -5.4% | |
| JNJ | JOHNSON AND JOHNSON | $1,371,000 | +12.7% | 9,400 | 0.0% | 0.47% | +3.1% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $1,320,000 | +6.3% | 100,000 | 0.0% | 0.45% | -3.0% | |
| SYBX | Buy | SYNLOGIC INC | $1,292,000 | +30.4% | 500,731 | +15.7% | 0.44% | +18.8% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $1,245,000 | -69.6% | 40,657 | -76.1% | 0.43% | -72.2% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $1,239,000 | +117.8% | 13,600 | +106.1% | 0.42% | +98.6% |
| PRVL | PREVAIL THERAPEUTICS INC | $1,187,000 | +28.9% | 75,000 | 0.0% | 0.41% | +17.6% | |
| NXTC | New | NEXTCURE INC | $1,127,000 | – | 20,000 | +100.0% | 0.39% | – |
| GNCA | GENOCEA BIOSCIENCES INC | $1,123,000 | -28.6% | 542,564 | 0.0% | 0.38% | -35.0% | |
| SCYX | Sell | SCYNEXIS INC | $1,099,000 | -19.0% | 1,207,413 | -5.1% | 0.38% | -26.1% |
| ARGX | Sell | ARGENX SEsponsored adr | $975,000 | -61.1% | 6,071 | -72.4% | 0.34% | -64.4% |
| MLND | New | MILLENDO THERAPEUTICS INC | $873,000 | – | 129,525 | +100.0% | 0.30% | – |
| CTMX | CYTOMX THERAPEUTICS INC | $831,000 | +12.6% | 100,000 | 0.0% | 0.28% | +2.5% | |
| XCUR | New | EXICURE INC | $787,000 | – | 275,000 | +100.0% | 0.27% | – |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $728,000 | +46.5% | 35,573 | -29.7% | 0.25% | +33.7% |
| INSM | INSMED INC | $716,000 | +35.3% | 30,000 | 0.0% | 0.25% | +23.6% | |
| GMDA | Sell | GAMIDA CELL LTD | $640,000 | -45.9% | 148,781 | -45.5% | 0.22% | -50.6% |
| MORF | New | MORPHIC HOLDING INC | $635,000 | – | 37,000 | +100.0% | 0.22% | – |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $621,000 | -21.7% | 108,463 | -78.4% | 0.21% | -28.5% |
| DEXCOM INCnote 0.750% 5/1 | $556,000 | +40.1% | 250,000 | 0.0% | 0.19% | +28.2% | ||
| MASI | MASIMO CORPORATION | $474,000 | +6.3% | 3,000 | 0.0% | 0.16% | -3.0% | |
| GRTS | GRITSTONE ONCOLOGY INC | $449,000 | +3.9% | 50,000 | 0.0% | 0.15% | -4.9% | |
| RDUS | RADIUS HEALTH INC | $444,000 | -21.7% | 22,000 | 0.0% | 0.15% | -28.6% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $440,000 | +53.3% | 24,725 | 0.0% | 0.15% | +39.8% | |
| STRO | SUTRO BIOPHARMA INC | $440,000 | +20.9% | 40,000 | 0.0% | 0.15% | +10.2% | |
| ZFGN | ZAFGEN INC | $339,000 | +50.0% | 305,500 | 0.0% | 0.12% | +36.5% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $337,000 | +14.2% | 157,700 | 0.0% | 0.12% | +4.5% | |
| ADXS | ADVAXIS INC | $300,000 | +222.6% | 350,000 | 0.0% | 0.10% | +194.3% | |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $296,000 | -92.7% | 36,960 | -81.3% | 0.10% | -93.3% |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $239,000 | – | 117,682 | +100.0% | 0.08% | – |
| URGN | Sell | UROGEN PHARMA LTD | $133,000 | -62.7% | 3,987 | -73.4% | 0.05% | -65.7% |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $85,000 | -8.6% | 95,000 | 0.0% | 0.03% | -17.1% | |
| EVLO | Sell | EVELO BIOSCIENCES INC | $44,000 | -63.9% | 10,726 | -46.4% | 0.02% | -67.4% |
| ORMP | Exit | ORAMED PHARMACEUTICALS INC | $0 | – | -16,000 | -100.0% | -0.02% | – |
| ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -99,502 | -100.0% | -0.02% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -11,192 | -100.0% | -0.07% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -99,993 | -100.0% | -0.08% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.08% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.10% | – |
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -39,395 | -100.0% | -0.16% | – |
| OBSV | Exit | OBSEVA SA | $0 | – | -64,231 | -100.0% | -0.20% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -920,995 | -100.0% | -0.25% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -104,000 | -100.0% | -0.25% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -127,500 | -100.0% | -0.34% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -305,500 | -100.0% | -0.35% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -349,996 | -100.0% | -0.67% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -21,210 | -100.0% | -0.69% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -636,013 | -100.0% | -4.51% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.